| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Revenue | $6.2B | $6.9B | $7.1B | $7.0B | $0.1B | $9.1B |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | $0.3B | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | $1.5B | $1.7B | $1.8B | $1.7B | $1.9B | $2.1B |
| Operating Income | — | — | — | — | — | — |
| Net Income | $-1.3B | $0.0B | $-0.3B | $-0.5B | $0.2B | $1.4B |
| EPS (Basic) | $-10.75 | $-0.09 | $-2.15 | $-2.56 | $0.85 | $6.03 |
| EPS (Diluted) | $-10.75 | $-0.09 | $-2.15 | $-2.56 | $0.84 | $5.80 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Total Assets | $8.4B | $10.0B | $11.5B | $13.2B | $14.7B | $15.0B |
| Current Assets | $2.9B | $3.2B | $4.1B | $4.7B | $5.8B | $6.1B |
| Cash & Equivalents | $0.6B | $0.5B | $1.0B | $1.8B | $2.6B | $2.7B |
| Total Liabilities | $7.1B | $7.2B | $8.0B | $8.6B | $8.9B | $9.2B |
| Current Liabilities | $2.6B | $2.8B | $3.3B | $2.8B | $2.5B | $3.4B |
| Stockholders' Equity | $1.1B | $2.5B | $3.3B | $4.4B | $5.6B | $5.6B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.7B | $0.2B | $0.6B | $0.5B | $1.3B |
| Investing Cash Flow | $-0.2B | $-0.0B | $-0.1B | $-0.1B | $-0.2B | $2.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.3B | $-1.2B | $-0.8B | $-1.3B | $-0.4B | $-1.8B |